title: Pneumocystis jiroveci (carinii) pneumonia after initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.
authors.forename: Mimouna
authors.initials: M
authors.lastname: Seddik
authors.forename: Hugues
authors.initials: H
authors.lastname: Melliez
authors.forename: David
authors.initials: D
authors.lastname: Seguy
authors.forename: Nathalie
authors.initials: N
authors.lastname: Viget
authors.forename: Antoine
authors.initials: A
authors.lastname: Cortot
authors.forename: Jean Frederic
authors.initials: JF
authors.lastname: Colombel
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D001379:Azathioprine / Q000009:adverse effects* / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000069285:Infliximab; D008297:Male; D045363:Pneumocystis carinii / Q000472:pathogenicity*; D011020:Pneumonia, Pneumocystis / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D001379:Azathioprine